Results 81 to 90 of about 1,271,617 (289)

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Additive Manufacturing and Chemical Engineering: Looking for Synergies from a Bibliometric Study

open access: yesApplied Sciences
Additive manufacturing must be highlighted as an innovative technology with the capacity to produce objects with complex and customized geometries using a diverse range of raw materials.
Rodrigo Estévez   +3 more
doaj   +1 more source

Machining dynamics: Fundamentals, applications and practices [PDF]

open access: yes, 2008
Information regarding this edited book can be found at this link:Machining dynamics play an essential role in the performance of machine tools and machining processes in manufacturing.
Cheng, K
core  

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Bibliometric analysis of model-based systems engineering in advanced manufacturing [PDF]

open access: yesJournal of Intelligent Manufacturing and Special Equipment
Purpose – Model-based systems engineering (MBSE) is an important approach for the transforming process from “document-centered” to “model centered” systems engineering mode in equipment development, which can effectively shorten the equipment development
Jinzhi Lu   +3 more
doaj   +1 more source

A Hands-On, Active Learning Approach to Increasing Manufacturing Knowledge in Engineering Students [PDF]

open access: yes, 2013
This paper describes a new learning module implemented as part of the senior capstone design course at Marquette University to teach engineering students about basic manufacturing processes, lean manufacturing principles, and design for manufacturability.
Goldberg, Jay R., Rank, David B.
core   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Developing a Virtual Laboratory Framework Based on the Lean Approach in Engineering Education: A Response to Industry 4.0 Skills

open access: yesEngineering Proceedings
The rapid advancement of digital technologies, referred to as Industry 4.0, has profoundly transformed the manufacturing landscape, necessitating a reevaluation of engineering education.
Khadija Talbi   +3 more
doaj   +1 more source

The adoption and use of Through-life Engineering Services within UK Manufacturing Organisations [PDF]

open access: yes, 2014
Manufacturing organisations seek ever more innovative approaches in order to maintain and improve their competitive position within the global market. One such initiative that is gaining significance is ‘through-life engineering services’.
Phillips, Paul   +4 more
core   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy